The developments at Holland Capital in 2024 reflect our strong ambitions
Amsterdam/ Düsseldorf, 30th of December 2024 –The developments at Holland Capital in 2024 reflect our strong ambitions. Guided by a focused investment strategy, we continued to actively engage in the high-growth markets of Technology, Healthcare, and Agrifood. Reflecting on a successful year, we completed several key transactions and further strengthened our team.
2024 achievements
- The launch of our fund, Holland Capital Growth and Buy-Out Fund V
- Number of deals in the Netherlands: 5
- Number of add-on acquisitions in the Netherlands: 13
- Number of add-on acquisitions in Germany: 2
- Number of exits: 2
- Number of new colleagues: 4
Sector focus and an entrepreneurial hands-on approach: With specialized sector teams, we focus on the sectors of Healthcare, Technology, and Agrifood, both within the Growth & Buy-out and Venture & Growth segments. We understand the dynamics and opportunities in these sectors and have an extensive network. Holland Capital is not a passive investor; we work closely with management to define and execute strategies. Where needed, our operational team also contributes hands-on to the realization of specific projects within the company.
Which companies would we like to connect with?
- Sector: Technology, Healthcare, and Agrifood
- Positive outlook: Significant growth potential, both autonomous and buy-and-build
- Growth & Buy-out:
- Healthy profitability: cash flow from operations (EBITDA) between EUR 1 – 10m
- Smaller companies: considered as add-on acquisitions for our existing portfolio companies
- Larger companies: considered together with a co-investor
- Venture & Growth:
- Start-ups and scale-ups: EBITDA EUR <1m
- Cash flow negative (in an accelerated growth scenario)
- Revenue EUR 0 – 5m
What to expect from us?
- Flexible approach to transaction structures: We strive to adapt each structure to the needs of the company and its shareholders. Depending on the type of investment, Holland Capital either provides growth capital and/or acquires existing shares. We are flexible regarding the final capital structure: both majority and minority stakes are possible.
- Deal certainty and an efficient process: Thanks to our sector expertise, we are able to quickly assess a business model and put a fair price on the table. Since the partnership with the entrepreneur and/or the management team is the cornerstone of our investment, we devote above-average attention to ensuring the process is completed efficiently, in the right spirit, and with mutual respect for both parties.
- Transparency towards advisors: We appreciate it when advisors involve us early in discussions with entrepreneurs and/or management teams. In such cases, we always ensure that the advisor’s interests are well safeguarded throughout the process. The advisor retains the flexibility to decide whether to represent the sell-side or buy-side in a potential transaction.
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and fosters an open, sustainable, and professional relationship with the management teams of the invested companies, aiming for mutual growth. With offices in Amsterdam and Düsseldorf, Holland Capital focuses on Healthcare, Technology, and Agrifood-Tech sector.
Sirius Medical benoemt leden Raad van Commissarissen en nieuwe CEO
Sirius Medical benoemt leden Raad van Commissarissen en nieuwe CEO Eindhoven, 12 mei 2021 - Sirius Medical, een MedTech-startup die een innovatieve chirurgisch technologie heeft ontwikkeld om een tumoren te lokaliseren, heeft vandaag de benoemingen van de leden van de...
Sirius Medical Establishes Highly Experienced Supervisory Board and Announces CEO Transition
Sirius Medical establishes highly experienced Supervisory Board and announces CEO transition Eindhoven, May 11th 2021 - Sirius Medical, a medical device start-up developing the next generation of tumor localization technology, today announced that medical device...
Wortell neemt Synergics over en breidt haar activiteiten uit naar België
Wortell neemt Synergics over en breidt haar activiteiten uit naar België Amsterdam, 10 mei 202 - Onze deelneming Wortell heeft het Belgische Synergics overgenomen. Daarmee breidt zij haar activiteiten uit naar België. Samen vormen zij de grootste Managed Service...
Avensus breidt cloud activiteiten uit met overname bosworX
Avensus breidt cloud activiteiten uit met overname bosworX Amsterdam, 12 april 2021 – Onze deelneming Avensus Groep neemt per 1 april 2021 IT-dienstverlener bosworX uit Apeldoorn over. bosworX richt zich met klantgerichte managed services op middelgrote...
Autisme specialist PGZ sluit zich aan bij Allerzorg
Autisme specialist PGZ sluit zich aan bij Allerzorg Amsterdam, 8 april 2021 – GGZ-aanbieder Zorgverlening PGZ sluit zich aan bij Allerzorg. PGZ is gespecialiseerd in de behandeling en begeleiding van kinderen, jongeren en volwassenen met (een vorm van) autisme. Het...
Wortell versterkt haar Data & AI positie en neemt Sigma Data Consulting over
Wortell versterkt haar Data & AI positie en neemt Sigma Data Consulting over Lijnden – 22 februari 2021 - De organisatie Sigma Data Consulting (SDC) is door Wortell overgenomen. SDC is een Data & AI specialist met meer dan 50 Business Intelligence, Data...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl